Ashenafi Sendekie | Pharmaceutical Policy and Regulation | Best Researcher Award

Mr Ashenafi Sendekie, Curtin University, Australia

Mr. Ashenafi Kibret Sendekie is a dedicated researcher and academic pursuing a Ph.D. at Curtin University, focusing on ethical dilemmas in pharmacist-administered vaccinations for children and adolescents. 🎓 He holds a Master’s in Clinical Pharmacy and a Bachelor’s in Pharmacy from the University of Gondar. 📚 With numerous publications in SJR Q1 journals, his research spans AI in pharmacy, mental health, and public health. 🧠 As a lecturer and former Head of Hospital Pharmacy, he excels in teaching, leadership, and community service. 💊 His commitment to healthcare ethics and professional development makes him a standout in pharmacy research. 🌍

Publication Profile

google scholar

Education

Ashenafi Sendekie is a dedicated scholar currently pursuing a Ph.D. in Pharmacy at Curtin University, Australia 🇦🇺 (2024–present). His research focuses on exploring pharmacists’ experiences and ethical dilemmas in administering vaccines to children and adolescents using a mixed-methods approach 💉📊. He earned a Diploma in Teaching Methodology from the University of Gondar, Ethiopia 🇪🇹 (2020–2021), and an MSc in Clinical Pharmacy from the same institution (2018–2020) 🧪📚. Ashenafi began his academic journey with a Bachelor of Science in Pharmacy from the University of Gondar (2009–2014) 🎓. His commitment to pharmacy and education exemplifies his passion for improving healthcare outcomes 🌟.

Professional Membership

Ashenafi Sendekie is a proactive professional serving as the Chairperson of the Ethiopian Pharmaceutical Association (EPA), Gondar Chapter Executive Committee, since January 2023 🌍💊. He is also an active member of the Ethiopian Public Health Association (EPHA) 🏥. Ashenafi is known for his exceptional skills, including being a fast learner 🧠, maintaining a positive attitude 🌟, and excelling in time management ⏳ and attention to detail 🔍. His strong communication skills 🗣️, reliability ⏰, computer proficiency 💻, and teamwork 🤝 make him a valuable asset in any setting. Ashenafi’s organizational expertise ensures efficiency and success in his endeavors 📋✔️.

Journals Reviewer

Ashenafi Sendekie has actively contributed to renowned international journals as an author and researcher 🖋️🌍. His work is featured in prestigious publications, including PLOS Global Public Health 🌐, BMJ Open 📖, and Nature (Scientific Reports) 🔬. He has also contributed to journals like Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 🩺, Patient Preference and Adherence 💊, and BMC Health Services Research 🏥. Other notable journals include F1000Research 🔎, BMC Endocrine 💡, Integrated Pharmacy Research and Practice ⚕️, and BMJ Open Respiratory Research 🌬️. Ashenafi’s scholarly efforts reflect his commitment to advancing global health and pharmacy research 📚✨.

Collaboration

Ashenafi Sendekie is a committed contributor to the Global Burden of Disease (GBD) Collaboration 🌍📊, based at the Institute for Health Metrics and Evaluation (Hans Rosling Center for Population Health) in Seattle, WA, USA 🇺🇸. Since December 17, 2024, he has served as a GBD Senior Collaborator 🌟, following his role as a GBD Collaborator from April 2023 to December 16, 2024 📈. Ashenafi’s work in this global initiative highlights his dedication to advancing population health and contributing to impactful research aimed at improving health outcomes worldwide 🌐✨.

Conferences

Ashenafi Sendekie has actively participated in key academic events and presented his work on an international stage 🌍🎤. He presented a paper at the 5th Annual Conference of the Australian-based Ethiopian Researchers Network (ABReN) on August 31, 2024 📅. He also took part in the International Pharmaceutical Federation (FIP) PPR SIG 2024 Virtual Meeting on July 4, 2024 💻. Additionally, Ashenafi delivered an oral presentation at the 43rd Annual Conference of the Ethiopian Pharmaceutical Association held in Addis Ababa, Ethiopia, from July 28-29, 2023 🇪🇹💊. His active involvement highlights his commitment to advancing pharmaceutical research and knowledge sharing 📚.

Honors and Awards

Ashenafi Sendekie has received numerous prestigious awards throughout his academic journey 🎓🏆. In November 2023, he was awarded the 2024 HDR Curtin Scholarship at Curtin University, Australia 🇦🇺, providing a tuition fee offset and a stipend of $33,220 per annum for three years, with a possible six-month extension 💵. Earlier, in August 2023, he was offered admission for a Doctor of Philosophy in Pharmacy at Curtin University 🧪. In November 2022, Ashenafi received the Community Service Project Award from the University of Gondar, Ethiopia 🇪🇹, for his project improving pharmacists’ roles in patient counseling 💬. He also received research and scholarship grants for his master’s studies in clinical pharmacy 💡.

Current Residence

Ashenafi Sendekie currently resides at UniLodge at Curtin University – Guild House 🏠, located at 21.2, 63 Jackson Road, Karawara, WA, 6152, Australia 🇦🇺. This accommodation provides him with a comfortable and convenient living space close to Curtin University, supporting his academic pursuits 🧑‍🎓. As a Ph.D. student in Pharmacy, Ashenafi is able to focus on his studies while enjoying a supportive community environment at UniLodge 🌟. The location offers access to university facilities and enhances his experience as an international student in Australia 🌍.

Research Focus

Dr. Ashenafi Sendekie is a researcher with a strong focus on pharmacology, medication adherence, and chronic disease management. His work investigates the impact of medications, particularly for conditions like type 2 diabetes, asthma, and psychiatric disorders, while emphasizing patient education, medication safety, and adverse drug reactions. Dr. Sendekie also explores healthcare delivery in Ethiopia, including the roles of community pharmacists and the quality of life in patients managing chronic diseases. His research aims to improve medication adherence, reduce drug interactions, and enhance patient outcomes in low-resource settings. 🩺💊📊

Publication Top Notes

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Medication adherence and its impact on glycemic control in type 2 diabetes mellitus patients with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia

Assessment of community pharmacy professionals’ knowledge and counseling skills achievement towards headache management: a cross-sectional and simulated-client based mixed study

Evaluation of antibiotics residues in milk and meat using different analytical methods

Impact of personal, cultural and religious beliefs on medication adherence among patients with chronic diseases at university hospital in Northwest Ethiopia

Potential drug-drug interactions and associated factors among admitted patients with psychiatric disorders at selected hospitals in Northwest Ethiopia

Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia

Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational …

Academic and Professional Background 🌟

Cao Zhen is a dedicated doctoral candidate at the School of Public Health, Capital Medical University, specializing in health policy and hospital management. With a robust academic foundation, Cao Zhen is a valued member of the Expert Pool for Project Funding Supervision at the National Health Commission. Her impressive track record includes overseeing two provincial and ministerial-level projects, participation in a National Social Science Foundation project, and contributing to numerous other provincial and ministerial-level initiatives. Her scholarly contributions are evidenced by the publication of nine academic papers in reputable journals.

Research and Innovations 🔬📊

Completed/Ongoing Research Projects: 15

Consultancy/Industry Projects: 2

Journals Published (SCI, Scopus, etc.): 9

Patents Published/Under Process: 2

Collaborations: Notably collaborated with the National Health Commission of the People’s Republic of China during the COVID-19 pandemic to study funding and material support for epidemic prevention and control, as well as the economic operation of hospitals. This collaboration provided crucial decision-making support to tackle pandemic-related challenges.

🎓Publication Top Noted:

Paper Title :Adenylyl cyclase localization to the uropod of aggregating Dictyostelium cells requires RacC

Authors: Sherly I Celada, Guoliang Li, Lindsay J Celada, Wenfu Lu, Thanigaivelan Kanagasabai, Weiran Feng, Zhen Cao, Nazifa Salsabeel, Ninghui Mao, LaKendria K Brown, Zaniya A Mark, Michael G Izban, Billy R Ballard, Xinchun Zhou, Samuel E Adunyah, Robert J Matusik, Xiaofei Wang, Zhenbang Chen

Journal: Molecular Oncology

Year:2023

Citations : 3

**Paper Title :Alternative transcription initiation leads to expression of a novel ALK isoform in cancer**

Authors: Thomas Wiesner, William Lee, Anna C Obenauf, Leili Ran, Rajmohan Murali, Qi Fan Zhang, Elissa WP Wong, Wenhuo Hu, Sasinya N Scott, Ronak H Shah, Iñigo Landa, Julia Button, Nathalie Lailler, Andrea Sboner, Dong Gao, Devan A Murphy, Zhen Cao, Shipra Shukla, Travis J Hollmann, Lu Wang, Laetitia Borsu, Taha Merghoub, Gary K Schwartz, Michael A Postow, Charlotte E Ariyan, James A Fagin, Deyou Zheng, Marc Ladanyi, Klaus J Busam, Michael F Berger, Yu Chen, Ping Chi
Journal: Nature
Year:2015
Citations : 240

Paper Title : Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth

Authors: Leili Ran, Inna Sirota, Zhen Cao, Devan Murphy, Yuedan Chen, Shipra Shukla, Yuanyuan Xie, Michael C Kaufmann, Dong Gao, Sinan Zhu, Ferdinando Rossi, John Wongvipat, Takahiro Taguchi, William D Tap, Ingo K Mellinghoff, Peter Besmer, Cristina R Antonescu, Yu Chen, Ping Chi
Journal: Cancer discovery
Year:2015
Citations :130

Paper Title :SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer

Authors:Ping Mu, Zeda Zhang, Matteo Benelli, Wouter R Karthaus, Elizabeth Hoover, Chi-Chao Chen, John Wongvipat, Sheng-Yu Ku, Dong Gao, Zhen Cao, Neel Shah, Elizabeth J Adams, Wassim Abida, Philip A Watson, Davide Prandi, Chun-Hao Huang, Elisa De Stanchina, Scott W Lowe, Leigh Ellis, Himisha Beltran, Mark A Rubin, David W Goodrich, Francesca Demichelis, Charles L Sawyers
Journal:Science
Year: 2017
Citations :905

Paper Title : Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation

Authors: Zeda Zhang, Chuanli Zhou, Xiaoling Li, Spencer D Barnes, Su Deng, Elizabeth Hoover, Chi-Chao Chen, Young Sun Lee, Yanxiao Zhang, Choushi Wang, Lauren A Metang, Chao Wu, Carla Rodriguez Tirado, Nickolas A Johnson, John Wongvipat, Kristina Navrazhina, Zhen Cao, Danielle Choi, Chun-Hao Huang, Eliot Linton, Xiaoping Chen, Yupu Liang, Christopher E Mason, Elisa de Stanchina, Wassim Abida, Amaia Lujambio, Sheng Li, Scott W Lowe, Joshua T Mendell, Venkat S Malladi, Charles L Sawyers, Ping Mu
Journal: Cancer cell
Year: 2020
Citations : 114